The platelet-activating factor antagonist BN 52021 attenuates hypoxic- ischemic brain injury in the immature rat

Pediatric Research

Volumn 40, Issue 6, 1996, Pages 797-803

  Liu, Xiao Hong ^a   Eun, Baik Lin ^a,b   Silverstein, Faye S ^a   Barks, John D E ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Korea University   (South Korea)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GINKGOLIDE B; N METHYL DEXTRO ASPARTIC ACID; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN MATURATION; BRAIN PROTECTION; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE ACTIVATION;

EID: 0029852757     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199612000-00004     Document Type: Article

References (45)

1. Barks JD, Silverstein FS 1992 Excitatory amino acids contribute to the pathogenesis of perinatal hypoxic-ischemic brain injury. Brain Pathol 2:235-243
2. Palmer C 1995 Hypoxic-ischemic encephalopathy: therapeutic approaches against microvascular injury, and role of neutrophils, PAF and free radicals. Clin Perinatol 22:481-517
3. Hudome SM, Roberts RL, Housman C, Towfighi J, Palmer C 1995 Interaction of allopurinol and neutropenia in the reduction of hypoxic-ischemic brain injury in the neonatal rat. Pediatr Res 37:380A(abstr)
4. Ivacko JA, Sun R, Silverstein FS 1996 Hypoxic-ischemic brain injury induces an acute microglial reaction in perinatal rats. Pediatr Res 39:39-47
5. McRae A, Gilland E, Bona E, Hagberg H 1995 Microglia activation after neonatal hypoxic-ischemia. Dev Brain Res 84:245-252
6. Szaflarski J, Burtrum D, Silverstein FS 1995 Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats. Stroke 26:1093-1100
7. Hagberg H, Soder O, Gilland E, McRae A, Bona E, Blennow M 1995 Interleukin-1 and hypoxic-ischemic brain injury in the neonatal rat. Pediatr Res 37:380A(abstr)
8. Martin D, Chinookoswong N, Miller G 1994 The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia. Exp Neurol 130:362-367
9. Doucet JP, Bazan NG 1992 Excitable membranes, lipid messengers, and immediate-early genes. Alteration of signal transduction in neuromodulation and neurotrauma. Mol Neurobiol 6:407-424
10. Koltai M, Guinot P, Hosford D, Braquet PG 1994 Platelet-activating factor antagonists: scientific background and possible clinical applications. Adv Pharmacol 28:81-167
11. Zablocka B, Lukasiuk K, Lazarewicz JW, Domanska-Janik K 1995 Modulation of ischemic signal by antagonists of N-methyl-D-aspartate, nitric oxide synthase, and platelet-activating factor in gerbil hippocampus. J Neurosci Res 40:233-240
12. Kunievsky B, Yavin E 1994 Production and metabolism of platelet-activating factor in the normal and ischemic fetal rat brain. J Neurochem 63:2144-2151
13. Kumar R, Harvey SA, Kester M, Hanahan DJ, Olson MS 1988 Production and effects of platelet-activating factor in the rat brain. Biochim Biophys Acta 963:375-383
14. Domingo MT, Spinnewyn B, Chabrier PE, Braquet P 1994 Changes in [H-3]PAF binding and PAF concentrations in gerbil brain after bilateral common carotid artery occlusion - a quantitative autoradiographic study. Brain Res 640:268-276
15. Yue TL, Feuerstein GZ 1994 Platelet-activating factor: a putative neuromodulator and mediator in the pathophysiology of brain injury. Crit Rev Neurobiol 8:11-24
16. Bito H, Honda Z, Nakamura M, Shimizu T 1994 Cloning, expression and tissue distribution of rat platelet-activating-factor-receptor cDNA. Eur J Biochem 221:211-218
17. Bonavida B, Mencia-Huerta JM 1994 Platelet-activating factor and the cytokine network in inflammatory processes. Clin Rev Allergy 12:381-395
18. Lindsberg PJ, Yue TL, Frerichs KU, Hallenbeck JM, Feuerstein G 1990 Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits. Stroke 21:1452-1457
19. Pettigrew LC, Meyer JJ, Craddock SD, Butler SM, Tai HH, Yokel RA 1995 Delayed elevation of platelet activating factor in ischemic hippocampus. Brain Res 691:243-247
20. Kato K, Clark GD, Bazan NG, Zorumski CF 1994 Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature 367:175-179
21. Izquierdo I, Fin C, Schmitz PK, Da Silva RC, Jerusalinsky D, Quillfeldt JA, Ferreira MBG, Medina JH, Bazan NG 1995 Memory enhancement by intrahippocampal, intraamygdala, or intraentorhinal infusion of platelet-activating factor measured in an inhibitory avoidance task. Proc Natl Acad Sci USA 92:5047-5051
22. Clark GD, Happel LT, Zorumski CF, Bazan NG 1992 Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron 9:1211-1216
23. 3H]-D-aspartate release after ischaemia in vitro. Neuroreport 6:85-88
24. Prehn JHM, Krieglstein J 1993 Platelet-Activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo. J Neurosci Res 34:179-188
25. Hofer RE, Christopherson TJ, Scheithauer BW, Milde JH, Lanier WL 1993 The effect of a platelet activating factor antagonist (BN 52021) on neurologic outcome and histopathology in a canine model of complete cerebral ischemia. Anesthesiology 79:347-353
26. Adachi H, Tsujimoto M, Hattori M, Arai H, Inoue K 1995 cDNA cloning of human cytosolic platelet-activating factor acetylhydrolase gamma-subunit and its mRNA expression in human tissues. Biochem Biophys Res Commun 214:180-187
27. Hattori M, Adachi H, Tsujimoto M, Arai H, Inoue K 1994 Miller-Dicker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase. Nature 370:216-218
28. Marcheselli VL, Rossowska MJ, Domingo MT, Braquet P, Bazan NG 1990 Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. J Biol Chem 265:9140-9145
29. Yager JY, Heitjan DF, Towfighi J, Vannucci RC 1992 Effect of insulin-induced and fasting hypoglycemia on perinatal hypoxic-ischemic brain damage. Pediatr Res 31:138-142
30. Barks JD, Nair MP, Schwartz SA, Silverstein FS 1993 Potentiation of N-methyl-D-aspartate-mediated brain injury by a human immunodeficiency virus-1-derived peptide in perinatal rodents. Pediatr Res 34:192-198
31. McDonald JW, Roeser NF, Silverstein FS, Johnston MV 1989 Quantitative assessment of neuroprotection against NMDA-induced brain injury. Exp Neurol 106:289-296
32. Konigsmark BW 1970 Methods for the counting of neurons. In: Nauta WJH, Ebbesson SOE (eds) Contemporary Research Methods in Neuroanatomy. Springer, New York, pp 315-340
33. Vannucci RC, Lyons DT, Vasta F 1988 Regional cerebral blood flow during hypoxia-ischemia in immature rats. Stroke 19:245-250
34. Mujsce DJ, Christensen MA, Vannucci RC 1990 Cerebral blood flow and edema in perinatal hypoxic-ischemic brain damage. Pediatr Res 27:450-453
35. Viswanath M, Palmer C, Roberts RL, Caplan MS 1996 Reduction of hypoxic ischemic brain injury in the neonatal rat with PAF antagonist WEB2170. Pediatr Res 39:382A(abstr)
36. Lefer AM, Weyrich AS, Buerke M 1994 Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injury. Cardiovasc Res 28:289-294
37. Panetta T, Marcheselli VL, Braquet P, Spinnewyn B, Bazan NG 1987 Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury. Biochem Biophys Res Commun 149:580-587
38. Bielenberg GW, Wagener G, Beck T 1992 Infarct reduction by the platelet activating factor antagonist apafant in rats. Stroke 23:98-103
39. Nishida K, Markey SP 1996 Platelet-activating factor in brain regions after transient ischemia in gerbils. Stroke 27:514-518
40. Feuerstein GZ 1996 Platelet-activating factor in brain regions after transient ischemia in gerbils [Editorial comment]. Stroke 27:518-519
41. Ikonomidou C, Mosinger JL, Salles KS, Labruyere J, Olney JW 1989 Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J Neurosci 9:2809-2818
42. Szaflarski J, Liu XH, Warren JS, Silverstein FS 1995 Systemic administration of anti-monocyte chemoattractant protein-1 antibody attenuates excitotoxic brain injury in perinatal rodents. Soc Neurosci Abstr 21:73
43. Hattori H, Morin AM, Schwartz PH, Fujikawa DG, Wasterlain CG 1989 Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat. Neurology 39:713-718
44. Hagberg H, Gilland E, Diemer N-H, Andiné P 1994 Hypoxia-ischemia in the neonatal rat brain: Histopathology after post-treatment with NMDA and non-NMDA receptor antagonists. Biol Neonate 66:205-213
45. Clark GD, McNeil RS, Bix GJ, Swann JW 1995 Platelet-activating factor produces neuronal growth cone collapse. Neuroreport 6:2569-2575